Kidney care provider Monogram Health raised USD 375 million in growth funding from several strategic investors including CVS Health, Humana, SCAN Health Plan, Cigna Ventures, and Memorial Hermann Health System, along with participation from other venture capital firms. This brings the total funds raised by the company to USD 577 million, its previous funding round of USD 160 million six months prior in June 2022. 

The funds will be used to continue to deploy the company’s clinical services and delivery model for its at-home kidney and chronic condition care service. The funding round also helps the company support its goal of growing its partnerships with healthcare investors.

The company currently provides its services across 34 states, with the company’s investors serving over 30% of Medicare Advantage customers and over 40% of the total US population.

Analyst QuickTake: This funding round marks the latest big-ticket activity in the kidney care space in recent history. In 2021, Strive Health raised USD 140 million, securing partnerships at the same time. Following this, 2022 saw Somatus raising USD 325 million and the merger of three of the space’s biggest players into one kidney care entity valued at USD 2.4 billion .